Epidural analgesia is associated with an increased rate of fever in prospective randomized trials. While the evidence suggests that epidural fever is not infectious, epidural analgesia has been associated with increased rates of antibiotic use, the indications that prompt treatment have not been examined.
INTRODUCTION
Epidural analgesia is the most effective form of pain relief available during labor and is preferred by over half of women. 1 However, epidural analgesia is associated with a more than four-fold increased rate of maternal fever in randomized trials [2] [3] [4] [5] [6] without corresponding increases in neonatal infection. 2 Although expert review suggests that epidural fever is not infectious in etiology, 7 no clinical or laboratory criteria accurately distinguish between chorioamnionitis and epidural fever. Therefore, epidural fever may potentially result in subsequent excess maternal antibiotic treatment. This association requires thorough examination. Although increased rates of maternal antibiotic use in patients with epidural analgesia have been previously reported, 8 the specific indications for antibiotic use were not included. This study evaluates the intrapartum characteristics of a low-risk population with and without epidural analgesia to investigate whether a higher rate of antibiotic administration is observed with epidural analgesia and, if so, what specific indications prompt antibiotic use.
STUDY DESIGN
The base sample for this study was 1934 nulliparous women enrolled in the active management of labor trial (ACT) conducted at Brigham & Women's Hospital from 1990 to 1994. Women were randomly assigned to either usual care or the active management of labor protocol. Epidural analgesia was available on request in both the usual care and active management groups. A complete description of the study methodology has been published elsewhere. 9 Most temperatures were measured orally (81%). Axillary temperatures were corrected upward a single degree Fahrenheit. 10, 11 The current analysis was limited to women with singleton, term pregnancies with cephalic presentation and the spontaneous onset of labor (n ¼ 1329). From this group, women were excluded if they were diabetic (n ¼ 33), or if birthweight was missing (n ¼ 4). Given that elevated maternal temperature was an important study variable, women were also excluded if they had an admission temperature of >99.51F (n ¼ 27), or no maternal temperatures were obtained (n ¼ 30). The remaining 1235 women comprised our study population.
Antibiotic use was classified into one of four categories by indication: (1) presumed chorioamnionitis based on physician diagnosis, (2) surgical prophylaxis for cesarean delivery, third or fourth degree perineal lacerations and manual placental extraction, (3) postpartum use for endometritis based on physician diagnosis and (4) medical use including such indications as antibiotic prophylaxis for mitral valve prolapse. Patients were not included in the postpartum use group if antibiotic treatment initiated during labor was continued in the postpartum period. At the time of this study, maternal group beta streptococcal (GBS) status was not routinely determined, nor were antibiotics given frequently for this indication.
Differences in maternal characteristics according to use of epidural analgesia were evaluated using the Student's t-test for continuous variables and w 2 or Fisher's exact test for categorical variables. Logistic regression was used to examine the association of antibiotic administration with epidural use while controlling for baseline differences between the epidural and no-epidural groups and to calculate adjusted odds ratios and 95% confidence intervals.
RESULTS
The final study group consisted of 1235 women. Of these, 736 women (59.6%) received epidural analgesia and 499 women (40.4%) did not. A comparison of the baseline characteristics of these two groups is presented in Table 1 . Self-selection resulted in underlying differences between women who received epidural analgesia and those who did not. On average, women who requested epidural analgesia were 0.4 inches shorter, 2.1 days farther along in gestational age, and had infants that were 82 g heavier than women who labored without epidural analgesia. In addition, women requesting epidural analgesia tended to be admitted with a less advanced cervical dilatation (2.9 vs 4.2 cm) and were less likely to have had their labor managed using the active management protocol (43.8 vs 55.9%). These differences were controlled for in subsequent analysis using logistic regression techniques.
Women who later requested epidural analgesia did not have subtle signs of infection at admission or at epidural placement based on temperature or white blood cell count ( Table 1 ). The mean temperature at admission was identical in the epidural and no-epidural groups, and there was no evidence of fever or lowgrade fever at the time of epidural placement. Indeed, women who later requested epidural analgesia had a somewhat lower white blood cell count at admission (12.5 vs 13.1 k/ml, p ¼ 0.005). The incidence of premature rupture of membranes (PROM) was similar in the epidural and no-epidural groups (17.9 vs 20.0%, p ¼ 0.51).
Overall, women with epidural analgesia were more likely to receive antibiotic treatment (28.0 vs 10.8%, RR ¼ 2.6, 95% CI ¼ 2.0, 3.4). Women with epidural analgesia were significantly more likely to receive antibiotics for maternal fever (RR ¼ 22.4, 95% CI ¼ 5.5, 90.9) and surgical prophylaxis (RR ¼ 2.9, 95% CI ¼ 1.9, 4.5, Table 2 ). There was no excess antibiotic administration for postpartum febrile illness or for other medical indications in women with epidural analgesia.
A more than 2.5-fold increased odds of antibiotic treatment persisted in logistic regression analysis (OR 2.6, 95% CI 1.8, 3.7)
controlling for gestational age, birthweight, maternal height, active management of labor, admission cervical exam and premature rupture of membranes. One important factor that we did not control for in our analysis was length of labor, as longer labor seen with epidural analgesia may be one of the mechanisms through which epidural analgesia results in an increased risk of fever. However, when length of labor is added to our regression model, epidural analgesia remains strongly associated with antibiotic use (OR 1.9, 95% CI 1.3, 2.7).
To determine the reason for this higher rate of antibiotic use, we examined the occurrence of labor characteristics associated with antibiotic treatment in both groups (Table 3) . Use of epidural analgesia was associated with an increased rate of maternal fever >100.41F (16.7 vs 0.6%, p ¼ 0.001) and cesarean delivery (15.9 vs 5.6%, p ¼ 0.001) in our population. In the group of women who delivered vaginally (n ¼ 1090), use of epidural analgesia was associated with an increased risk of third or fourth degree perineal laceration (18.9 vs 14.0%, p ¼ 0.02). Not unexpectedly, epidural analgesia was associated with longer labors. The mean length of labor in the epidural group was 11.4 hours compared with 6.7 hours in women without epidural analgesia (p ¼ 0.0001).
Finally, we examined the proportion of antibiotic use for maternal fever and surgical prophylaxis associated with epidural (Table 4) . Observed cases of antibiotic use for each indication in our population with an epidural rate of 59.6% were compared to the expected number of cases if the entire population had a rate of antibiotic use identical to the women in our study without epidural analgesia. Overall, comparison of observed and expected rates indicates that 93% of antibiotic treatment for maternal fever and 46% of antibiotic treatment for surgical prophylaxis are associated with epidural analgesia use.
DISCUSSION
In our study of term, low-risk nulliparas, epidural analgesia is associated with a 2.6-fold increased rate of antibiotic use. While the majority of this association is related to the increased rate of fever in women with epidural analgesia in our population, a portion of the increased risk of antibiotic treatment can also be linked to the increased rate of cesarean delivery and third and fourth degree perineal laceration among women who received epidural analgesia.
Antibiotic Treatment for Maternal Fever
No well-designed randomized trial has been performed to specifically address the issue of epidural-associated fever. However, studies where women were randomized to receive epidural analgesia or parenteral agents for other objectives have consistently shown an increased rate of fever in the epidural analgesia group. [2] [3] [4] [5] [6] In the two randomized studies where nulliparas can be analyzed separately, the relative risk for fever in the epidural analgesia group was between 4.8 and 5.0. 2, 6 Epidural fever is one of the most common side effects of epidural analgesia in nulliparas where the excess rate of fever is 19 to 26% compared to controls without epidural analgesia. 2, 6, 12 In our term, low-risk population, 97.6% of all maternal fever occurred in nulliparas with epidural analgesia.
The etiology of epidural fever is not known. Women randomized to epidural analgesia have longer labors and are more likely to require oxytocin, 6 which in turn may trigger increases in the rate of intrauterine pressure catheter (IUPC) use. Therefore, it is not surprising that we also observed these differences in our study cohort. However, women who receive epidural analgesia have higher rates of fever when compared to controls when stratified by length of labor, and women with prolonged labors without epidural analgesia do not have an increased risk of fever. 13 Therefore, while labor perturbations with epidural analgesia may by one mechanism by which epidural analgesia results in a higher rate of *Expected number of cases if the overall population rates were the same as in the no-epidural group. Computed as (rate in women not using epidural analgesia) Â (1235 women in study population). w Percent of cases associated with epidural analgesia use was computed as (observedÀexpected)/(observed).
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fever, these changes may not completely explain the large excess rates of fever. A recent expert review suggests that epidural fever is unlikely to be due to infection. 7 Current studies suggest that epidural fever may have a noninfectious inflammatory component. Maternal and fetal interleukin-6 (IL-6) levels increase with increasing length of exposure to epidural analgesia in the absence of any evidence for infection.
14 In addition, placental inflammation is more common with epidural analgesia (61 vs 36%), 15 and the substantial rate of placental pathology far exceeds any expected rate of infection. Further, while infants of women randomized to epidural analgesia have a 1.5-fold increase (95% CI 1.1, 2.0) in neonatal sepsis evaluations largely due to maternal fever, 2 there is no increased risk of neonatal sepsis.
2,13 Finally, we did not find any evidence that women who later request epidural analgesia are more likely to manifest subtle signs of infection at admission. The unexpected finding of a statistically significant lower admission white blood cell count in the epidural analgesia group may be related to the linear relationship between uterine activity and leukocytosis. 16 Women who later request epidural analgesia present with less cervical dilation (2.9 vs 4.2 cm) suggesting that they may have labored for a shorter interval at home.
There are several implications of increased rates of fever with epidural analgesia. The diagnosis of chorioamnionitis in labor is largely made on the basis of intrapartum fever, 17 especially in the setting of epidural analgesia which may mask fundal tenderness. Unfortunately, no criteria exist to distinguish epidural-related fever from true infection. Therefore, epidural-related fever prompts an increased rate of maternal antibiotic use for presumed chorioamnionitis. It is interesting to note that, in our study, not all women with fever received antibiotic treatment for chorioamnionitis. In the epidural analgesia group, only 66% of women who developed a fever were treated with intrapartum antibiotics. Of the 42 untreated febrile women, only one required treatment in the postpartum period. Thus, despite inconsistent treatment for presumed chorioamnionitis, there was no evidence of an increased rate of postpartum endometritis. This finding further strengthens the unlikely role of infection in the etiology of epidural fever.
Antibiotic Treatment for Surgical Prophylaxis
A second finding of our study was the 2.9-fold increased rate of antibiotic treatment for surgical prophylaxis in women with epidural analgesia. Overall, 46% of antibiotic treatment for surgical prophylaxis was associated with epidural analgesia; however, the underlying causes of this association are complex. We attribute this increased rate of treatment to the increased risk of cesarean delivery and third or fourth degree laceration associated with epidural analgesia in our study population. Several randomized prospective studies have shown an increased risk of cesarean delivery with epidural analgesia, 4, 18 while others have shown no increased risk with epidural analgesia 3, 6 or combined spinal-epidural analgesia. 5 Less controversial is the causal role of epidural analgesia in an increased risk of a second stage longer than 2 hours 4,5 in women with epidural analgesia contributing to the higher rates of operative vaginal delivery seen in most prospective studies. A summary statistic of the four best prospective studies [3] [4] [5] 18 where elective forceps were not allowed yields a relative risk of 1.9 for forceps delivery in the setting of epidural analgesia (95% CI 1.4, 2.5). Excess operative vaginal deliveries have been implicated in the increased rate of third and fourth degree lacerations seen in women with epidural analgesia. 19 
STUDY LIMITATIONS
As our study is observational, women chose whether to receive epidural analgesia, resulting in underlying differences between women receiving epidural analgesia and those who did not. While we controlled for known differences using logistic regression techniques, unrecognized confounders likely remain. Thus, while the strong prospective association between epidural analgesia and intrapartum fever in randomized trial supports our finding of increased maternal antibiotic treatment, the observational design of our study may result in an overestimation of this association. In addition, because nulliparous women are at higher risk than multiparous women for epidural-associated fever, our study design may overestimate the risk of antibiotic treatment in mixed populations. A more accurate estimation of the underlying association between epidural analgesia and maternal antibiotic treatment can only be derived from future randomized trials that examine this end point. Finally, this study was performed prior to widespread protocols designed to decrease neonatal GBS infection. 20 However, increasing concern regarding GBS infection may lead to an increased rate of antibiotic treatment, especially in institutions choosing to follow guidelines based on clinical risk factors such as intrapartum fever.
CONCLUSIONS
Epidural analgesia remains the most effective means of pain relief for the laboring woman and should be available to women. However, more complete information related to potential side effects of epidural analgesia should also be available. Discussion of intrapartum pain control should occur prior to the onset of labor so that women have an opportunity to weigh the risks and benefits of available methods.
